The global demand for veterinary healthcare, in terms of revenue, was estimated to be USD 33.68 billion in 2018 and is expected to reach USD 49.85 billion in 2018, growing at a CAGR of 5.79% from 2019 to 2025. Veterinary Healthcare demand is expected to be primarily driven by increase in population and necessity of nutrients in North America, Europe and Asia Pacific.
An increasing number of diseases in animals is also driving the need of healthcare product. Rising awareness about the animal healthcare products, vaccines of different type of veterinary healthcare and increasing technologically advance devices are also supplementing the market growth. Globally, rapidly growing livestock farming, poultry farm and pet adoption are also augmenting the veterinary healthcare market growth. Moreover, increasing number of veterinary healthcare companies and healthcare centers are also fostering the global veterinary healthcare market.
The study provides a decisive view of the global veterinary healthcare market by segmenting the market based on product, animal type and region. Based on product type, veterinary healthcare market is segmented into therapeutics (medicinal feed additives, nutritional feed additives, vaccines, anti-infectives, parasiticides and other pharmaceuticals) diagnostic tools (immunodiagnostic tests, molecular diagnostics, clinical chemistry, diagnostic imaging and other diagnostic tools).
With that said, Brandessence Market Research has announced the Top 7 Companies in The Veterinary Healthcare Market.
Virbac manufactures and sells medicines and vaccines to enhance the health of food-producing animals. Company was founded in 1968 and is headquartered in Carros cedex, France. Company operates through three business segments which includes; companion animals, food producing animals and other businesses. Company sells its health products in more than 100 countries. Linking the needs of health care providers to the latest technological advances, it offers a practical and comprehensive range of products and services covering the majority of species and pathologies. Company has a headcount of 4,900 as of 2017. It has production sites in 10 countries with sales subsidiaries in 33 countries. Company has R & D centers in five continents.
SeQuent is one of the India?s first integrated, global animal health companies, founded in 1985 and headquartered in Maharashtra, India. It offers API, branded generic formulations and analytical services. Company has manufacturing facilities in 5 countries, marketing presence in over 100 nations and employs 1,000+ people. Over the past four years, it has invested more than US$ 80 million in its business, strengthening its R&D and manufacturing capabilities, and building market presence through its differentiated portfolio. Sequent Scientific Limited has branded its animal health division as "Alivira". The API business is characterised by long established relationships with global top 10 animal health companies. Alivira has a formulations footprint in 80+ countries with 500+ formulations in 12 dosage forms. Company have seven manufacturing facilities based in India, Spain, Germany, Brazil and Turkey with approvals from global regulatory bodies, including the USFDA and EUGMP, among others. Company operates through two business segments; ALIVIRA animal health and analytical solutions. Company is one of the leading contract research organizations specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies
Ceva Santé Animale is one of the largest animal health companies in the world, was founded in 1999 and headquartered in Libourne, France. Company is based in 45 countries and working across more than 110. Company has 13 R&D centres, 25 production sites and more than 5,700 employees worldwide. Company's major product portfolio categorized into; companion animals, cattle, poultry, small ruminants and swine. Company is engaged in research, development, production and marketing of pharmaceutical products and vaccines, and also provides complementary services and equipment, for companion animals, poultry, ruminants and swine. It also offers; pheromone-based behavioural products for cats and dogs with additional knowledge in companion animal cardiology, locomotion and dermatology; hatchery vaccines, vaccination services and equipment; products for the management of reproduction in ruminants such as antibiotic therapies and vaccines; and a growing range of products for swine, including antibiotic therapies, reproduction management and vaccines. It has four main international sites and 19 regional production sites around the world (mainly for our biological products). Global business operations are divided into six major zones: North America/Pacific, Europe, Oceania, Latin America, Africa/Middle East, Eastern Europe and Turkey and Asia.
Vetoquinol S.A. was established in 1933 and headquartered in France. Company is specialized in the research, development, manufacture and sale of veterinary drugs and products across worldwide. The Company?s product portfolio is separated between livestock such as cattle and pigs and companion animals such as dogs and cats. It provides a wide range of products includes; anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine that is used for dogs and cats. The Company offers nearly over 700 products in various countries such as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. It trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In 2014, company acquired Bioniche's animal health business.
IDVet was established in 2004 and based in France. Company develops, manufacture and market a comprehensive range of mycoplasma diagnostic tests including both ELISA and PCR kits. IDvet is a science-based company incorporating the R&D activities in order to ensure that company?s products involve the cuttingedge of ELISA technology and allow them to continuously launch new and innovative tests. IDvet exports the wide range of products in many countries and established themselves as one of the significant players in the veterinary diagnostics field.
Bayer AG is a German based multinational pharmaceutical and life sciences company and one of the major pharmaceutical companies in the world. Bayer's areas of business includes; human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The Company offers the products; aspirin, antibiotics, anti-invectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes. In agriculture segment it produces products of category such as fungicides, herbicides and insecticides. It specializes in pharmaceuticals, consumer health, crop science, animal health, life sciences, research, innovation, sustainability, health care, digital farming, food security, science for an better life, and life sciences.
Boehringer Ingelheim GmbH functions as a pharmaceutical company. The Company researches, develops, and manufactures pharmaceutical products, as well as delivers prescription medicines and consumer health care products for human and animal health. The company specializes in pharmaceuticals, animal health, innovation, research, health care, improve health, biopharmaceuticals, and contract manufacturing. Boehringer Ingelheim mainly works in human pharmaceuticals, animal health, and biopharmaceuticals. The group comprises of 145 affiliated companies with around 50,000 employees in 2017 in all regions. Company has research and development facilities in five sites and 20 production plants in 13 countries. The research and development laboratories are located in Biberach (Germany), Ridgefield (Connecticut), Vienna and Kobe. More than 8,000 employees work for Boehringer Ingelheim in research and development.